Diversified Healthcare Trust
DHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $388,706 | $382,712 | $386,864 | $379,619 |
| % Growth | 1.6% | -1.1% | 1.9% | – |
| Cost of Goods Sold | $325,387 | $312,580 | $314,350 | $315,443 |
| Gross Profit | $63,319 | $70,132 | $72,514 | $64,176 |
| % Margin | 16.3% | 18.3% | 18.7% | 16.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $12,789 | $11,177 | $9,000 | $1,245 |
| SG&A Expenses | $12,789 | $11,177 | $9,000 | $1,245 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $65,324 | $66,266 | $0 | $0 |
| Operating Expenses | $78,113 | $77,443 | $9,000 | $1,245 |
| Operating Income | -$14,794 | -$7,311 | $63,514 | $62,931 |
| % Margin | -3.8% | -1.9% | 16.4% | 16.6% |
| Other Income/Exp. Net | -$148,909 | -$83,485 | -$72,451 | -$150,415 |
| Pre-Tax Income | -$163,703 | -$90,796 | -$8,937 | -$87,484 |
| Tax Expense | $337 | $843 | $49 | -$38 |
| Net Income | -$164,040 | -$91,639 | -$8,986 | -$87,446 |
| % Margin | -42.2% | -23.9% | -2.3% | -23% |
| EPS | -0.68 | -0.38 | -0.037 | -0.36 |
| % Growth | -78.9% | -916% | 89.6% | – |
| EPS Diluted | -0.68 | -0.38 | -0.037 | -0.36 |
| Weighted Avg Shares Out | 240,385 | 240,132 | 239,959 | 239,950 |
| Weighted Avg Shares Out Dil | 240,385 | 240,132 | 239,957 | 239,949 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,982 | $2,099 | $1,735 |
| Interest Expense | $0 | $50,926 | $57,831 | $59,518 |
| Depreciation & Amortization | $65,353 | $66,294 | $68,351 | $77,530 |
| EBITDA | -$53,773 | $23,342 | $63,540 | $65,443 |
| % Margin | -13.8% | 6.1% | 16.4% | 17.2% |